EBS R&D Expenses
Emergent Biosolutions Inc · R&D Expenses
EBS R&D Expenses
Latest reported$9.20Mperiod ending
EBS Quarterly R&D Expenses ($57.60M → $9.20M)
Quarterly R&D Expenses
High-resolution chart · PNG
EBS r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 9,200,000 | |
| 10,500,000 | |
| 12,100,000 | |
| 13,500,000 | |
| 13,000,000 | |
| 15,200,000 | |
| 9,100,000 | |
| 13,800,000 | |
| 32,700,000 | |
| 15,100,000 | |
| 29,400,000 | |
| 15,300,000 | |
| 26,000,000 | |
| 40,700,000 | |
| 47,000,000 | |
| 42,200,000 | |
| 52,700,000 | |
| 46,400,000 | |
| 83,000,000 | |
| 49,600,000 | |
| 48,900,000 | |
| 52,500,000 | |
| 59,500,000 | |
| 84,400,000 | |
| 47,900,000 | |
| 42,700,000 | |
| 62,800,000 | |
| 53,400,000 | |
| 63,900,000 | |
| 46,100,000 | |
| 52,000,000 | |
| 37,000,000 | |
| 24,700,000 | |
| 29,100,000 | |
| 28,514,000 | |
| 22,659,000 | |
| 25,751,000 | |
| 20,476,000 | |
| 27,117,000 | |
| 27,188,000 | |
| 27,893,000 | |
| 26,093,000 | |
| 25,353,000 | |
| 34,179,000 | |
| 20,952,000 | |
| 38,702,000 | |
| 38,465,000 | |
| 44,707,000 | |
| 37,401,000 | |
| 30,256,000 | |
| 29,994,000 | |
| 28,937,000 | |
| 30,278,000 | |
| 30,724,000 | |
| 35,945,000 | |
| 27,390,000 | |
| 30,645,000 | |
| 26,246,000 | |
| 29,376,000 | |
| 29,216,000 | |
| 31,481,000 | |
| 34,759,000 | |
| 29,615,000 | |
| 21,156,000 | |
| 18,602,000 | |
| 19,922,000 | |
| 19,226,000 | |
| 18,772,000 | |
| 20,680,000 | |
| 15,910,000 | |
| 14,162,000 | |
| 16,627,000 | |
| 17,206,000 | |
| 11,475,000 | |
| 12,269,000 | |
| 12,777,000 | |
| 13,342,000 | |
| 15,570,000 | |
| 18,861,000 | |
| 8,880,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 57,600,000 | |
| 49,600,000 | |
| 26,000,000 | |
| 46,400,000 | |
| 57,600,000 |